Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2003
10/16/2003WO2002100826A3 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2002072009A3 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195239 Heterocyclic esters such as 6-cyclopentyl-6-(4-phenyl-but-3-ynyl)-dihydropyran-2,4-dione, used as enzyme inhibitors or for prophylaxis of virus infections
10/16/2003US20030195238 Enzyme inhibitors
10/16/2003US20030195234 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/16/2003US20030195231 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195213 A methylene-4-oxo-2-thionothiazolidin derivatives viricides for treating infections caused by Flavivirous
10/16/2003US20030195204 Quinoline derivatives as NK3 antagonists
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030195145 Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives
10/16/2003US20030192138 Novel benzothiazine dyes for imaging elements
10/16/2003CA2694410A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481706A1 Antidiabetic agents
10/16/2003CA2481701A1 Benzoxazinone-derived compounds, their preparation and use as medicaments
10/15/2003EP1352900A1 Process to prepare taxol
10/15/2003EP1352899A1 Process to prepare taxol
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351954A1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351937A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351691A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003EP1098890B1 Dihydrotriazolone derivatives as pesticides
10/15/2003EP0973747B1 Pesticidal 1-arylpyrazoles
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003EP0855391B1 Novel isoquinoline derivatives
10/15/2003CN1449493A Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/15/2003CN1449395A Process for preparing azacycloalkanoyl aminothiazoles
10/15/2003CN1448392A Methionyl aminopeptidase inhibitor
10/14/2003US6632947 Process for the preparation of substituted thiazolidinedione
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082988A1 Nir-fluorescent cyanine dyes, their synthesis and biological use
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082861A2 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082848A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082840A1 κ-OPIOID RECEPTOR AGONIST COMPRISING 2-PHENYLBENZOTHIAZOLINE DERIVATIVE
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082838A1 New methionine aminopeptidase inhibitor
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082278A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/09/2003WO2003082277A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003WO2003052058A3 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
10/09/2003WO2002030357A9 Compounds and methods for modulating ccr4 function
10/09/2003US20030191320 Process for the preparation of bis-benzazolyl compounds
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191307 2,4-Diaminopyrimidine compounds useful as immunosuppressants
10/09/2003US20030191171 Insecticidal and acaricidal agent
10/09/2003US20030191168 Binding to nucleic acids
10/09/2003US20030191167 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191155 Triazole derivatives
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191139 Anticoagulant for mammals
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191113 For agriculture
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191089 Anticancer agents
10/09/2003US20030191067 Hepatitis C inhibitor tri-peptides
10/09/2003US20030190540 Photoconductive layer containing azo compound; electrostaticlatent image
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2480679A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2480106A1 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 628